A single six‑minute clip of HENGE’s track “DNA” has turned a Manchester‑based trio into a worldwide touring force. The band’s new 75‑date world tour will sweep the United Kingdom, Ireland, Europe, Canada, the United States and Mexico, with the first leg kicking off in March and April 2027.

The tour launch follows a surge in HENGE’s global profile after the “DNA” video amassed more than six million views across social media platforms. The clip, which showcases the group’s signature blend of rave‑style visuals, progressive rock structures and science‑fiction imagery, helped fill venues and introduced their high‑energy live style to a broader audience. Critics have praised the band’s immersive performances, noting how they translate studio experimentation into a compelling stage experience.

Formed in 2015, HENGE has released three full‑length albums to date. Their debut EP, Attention Earth! (2018), set the stage for ExoKosm (2020). The most recent release, Alpha Test 4 (2023), was produced by Jim Spencer—known for work with New Order and Black Grape—and mastered at Abbey Road Studios by Frank Arkwright, whose résumé includes Arcade Fire, Joy Division and Blur. The album received positive reviews, with NARC awarding it four stars and PROG describing it as “blissed‑out, retro‑futuristic madness.”

The 75‑show schedule marks HENGE’s first foray into North America and the most extensive European run the band has undertaken. In addition to the UK and Irish dates, the tour will include shows in Canada, the United States and Mexico, with further destinations to be announced. The band has hinted that new material is in development, suggesting a possible follow‑up release in the near future.

HENGE’s live reputation was cemented at major festivals, including Glastonbury, Boomtown, Bluedot, Shambala, Beatherder, Fusion, Down The Rabbit Hole and Jungle Love. Their performances earned them the Best Live Act award at the Independent Festival Awards, a testament to their ability to translate studio experimentation into a compelling stage experience.

The UK and Ireland leg of the tour, scheduled for March and April 2027, includes the following dates:

10 March – The 1865, Southampton 11 March – Phoenix, Exeter 12 March – The Globe, Cardiff 13 March – Trinity, Bristol 14 March – The Castle & Falcon, Birmingham 17 March – Crookes Social Club, Sheffield 18 March – Cambridge Junction, Cambridge 19 March – Chalk, Brighton 20 March – Village Underground, London 21 March – The Waterfront, Norwich 24 March – Saint Luke’s, Glasgow 25 March – The Grove, Newcastle 26 March – New Century, Manchester 27 March – Brudenell Social Club, Leeds 31 March – Rescue Rooms, Nottingham 1 April – The Invisible Wind Factory, Liverpool 3 April – Academy, Dublin 4 April – Belfast Empire Music Hall, Belfast

These venues are among the most respected independent spaces in the UK, and the tour’s route reflects HENGE’s long‑standing connection to grassroots music culture.

Industry observers note that a 75‑show schedule is ambitious for a band that has largely operated outside the mainstream. The scale of the tour, combined with the band’s recent viral success and critical acclaim, suggests that HENGE is positioning itself for a broader international presence. The addition of North American dates and the hint of forthcoming material indicate a strategic push to expand the band’s reach.

As the tour dates are confirmed, ticket sales are expected to open in late May, with the first UK and Irish shows selling out quickly. Fans and industry analysts alike will be watching to see how HENGE’s blend of electronic crossover rock translates to larger venues and new audiences.

In summary, HENGE’s 75‑date world tour represents a significant expansion of the band’s touring footprint, bringing their distinctive live experience to a global audience for the first time. The tour’s combination of UK, Irish, European, Canadian, American and Mexican dates, along with the band’s recent viral momentum and forthcoming new music, positions HENGE as a rising act to watch in the coming years.